Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

被引:395
作者
Bickerstaff, MCM
Botto, M
Hutchinson, WL
Herbert, J
Tennent, GA
Bybee, A
Mitchell, DA
Cook, HT
Butler, PJG
Walport, MJ
Pepys, MB [1 ]
机构
[1] Imperial Coll Sch Med, Hammersmith Hosp, Immunol Med Unit, London W12 0NN, England
[2] Imperial Coll Sch Med, Hammersmith Hosp, Rheumatol Sect, London W12 0NN, England
[3] Imperial Coll Sch Med, Hammersmith Hosp, Dept Histopathol, London W12 0NN, England
[4] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/9544
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum amyloid P component (SAP), a highly conserved plasma protein named for its universal presence in amyloid deposits', is the single normal circulating protein that shows specific calcium-dependent binding to DNA and chromatin in physiological conditions(2,3). The avid binding of SAP displaces Hi-type histones and thereby solubilizes native long chromatin, which is otherwise profoundly insoluble at the physiological ionic strength of extracellular fluids(4). Furthermore, SAP binds in vivo both to apoptotic cells(5), the surface blebs of which bear chromatin fragments(6), and to nuclear debris released by necrosis(7). SAP may therefore participate in handling of chromatin exposed by cell death(2-4,7). Here we show that mice with targeted deletion of the SAP genes spontaneously develop antinuclear autoimmunity and severe glomerulonephritis, a phenotype resembling human systemic lupus erythematosus, a serious autoimmune disease. The SAP(-/-) mice also have enhanced anti-DNA responses to immunization with extrinsic chromatin, and we demonstrate that degradation of long chromatin is retarded in the presence of SAP both in vitro and in vivo. These findings indicate that SAP has an important physiological role, inhibiting the formation of pathogenic autoantibodies against chromatin and DNA, probably by binding to chromatin and regulating its degradation.
引用
收藏
页码:694 / 697
页数:4
相关论文
共 28 条
  • [1] Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
    Botto, M
    Hawkins, PN
    Bickerstaff, MCM
    Herbert, J
    Bygrave, AE
    McBride, A
    Hutchinson, WL
    Tennent, GA
    Walport, MJ
    Pepys, MB
    [J]. NATURE MEDICINE, 1997, 3 (08) : 855 - 859
  • [2] Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
    Botto, M
    Dell'Agnola, C
    Bygrave, AE
    Thompson, EM
    Cook, HT
    Petry, F
    Loos, M
    Pandolfi, PP
    Walport, MJ
    [J]. NATURE GENETICS, 1998, 19 (01) : 56 - 59
  • [3] SERUM AMYLOID-P COMPONENT BINDS TO CELL-NUCLEI INVITRO AND TO INVIVO DEPOSITS OF EXTRACELLULAR CHROMATIN IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BREATHNACH, SM
    KOFLER, H
    SEPP, N
    ASHWORTH, J
    WOODROW, D
    PEPYS, MB
    HINTNER, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) : 1433 - 1438
  • [4] SUBNUCLEOSOME STRUCTURES AS SUBSTRATES IN ENZYME-LINKED IMMUNOSORBENT ASSAYS
    BURLINGAME, RW
    RUBIN, RL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 134 (02) : 187 - 199
  • [5] Burlingame RW, 1996, J IMMUNOL, V156, P4783
  • [6] PENTRAXIN-CHROMATIN INTERACTIONS - SERUM AMYLOID-P COMPONENT SPECIFICALLY DISPLACES H1-TYPE HISTONES AND SOLUBILIZES NATIVE LONG CHROMATIN
    BUTLER, PJG
    TENNENT, GA
    PEPYS, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) : 13 - 18
  • [7] AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES
    CASCIOLAROSEN, LA
    ANHALT, G
    ROSEN, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1317 - 1330
  • [8] DUCLOS TW, 1989, J IMMUNOL, V143, P2553
  • [9] STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID-P COMPONENT
    EMSLEY, J
    WHITE, HE
    OHARA, BP
    OLIVA, G
    SRINIVASAN, N
    TICKLE, IJ
    BLUNDELL, TL
    PEPYS, MB
    WOOD, SP
    [J]. NATURE, 1994, 367 (6461) : 338 - 345
  • [10] Gauthier VJ, 1996, J IMMUNOL, V156, P1151